- Cyclooxygenase 2 Inhibitors -- therapeutic use1
- Disclosure2
- Drug Approval1
- Drug Development1
- Drug Evaluation1
- Drugs, Investigational2
- Electromagnetic Fields -- adverse effects1
- Endpoint Determination1
- Equipment Safety -- standards1
- Facility Design and Construction1
- Frail Elderly1
- Hematologic Neoplasms -- drug therapy1
- Humans8
- Investigational New Drug Application1
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy1
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy1
- Leukemia, Myeloid, Acute -- drug therapy1
- Leukemia, Promyelocytic, Acute -- drug therapy1
- Lung Diseases -- drug therapy1
- Magnetic Resonance Imaging -- adverse effects1